U.S. Digital Diabetes Management Market, 2026-2033
- MedTech
- Diabetes Care
- digital diabetes management market
- Diabetes Care
Global Market
Related Markets
Ask a question about the digital diabetes management market
U.S. digital diabetes management market highlights
- The U.S. digital diabetes management market generated a revenue of USD 4,674.6 million in 2025 and is expected to reach USD 9,322.8 million by 2033.
- The U.S. market is expected to grow at a CAGR of 9.2% from 2026 to 2033.
- In terms of segment, continuous glucose monitoring systems was the largest revenue generating product in 2025.
- Smart Insulin Pens is the most lucrative product segment registering the fastest growth during the forecast period.
Digital diabetes management market data book summary
| Market revenue in 2025 | USD 4,674.6 million |
| Market revenue in 2033 | USD 9,322.8 million |
| Growth rate | 9.2% (CAGR from 2026 to 2033) |
| Largest segment | Continuous glucose monitoring systems |
| Fastest growing segment | Smart Insulin Pens |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Smart Glucose Meters, Continuous Glucose Monitoring Systems, Smart Insulin Pens, Smart Insulin Pumps/Closed Loop Systems, Apps |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, Roche Holding AG ADR, Bayer AG, Sanofi SA, DexCom Inc, Insulet Corp, PHC Holdings Corp, B. Braun Medical, Brigade High Income Founders |
Other key industry trends
- In terms of revenue, U.S. accounted for 32.4% of the global digital diabetes management market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. digital diabetes management market is projected to lead the regional market in terms of revenue in 2033.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 9,322.8 million by 2033.
In North America, the U.S. dominated the market owing to a high prevalence of diabetes and the availability of favorable reimbursement policies. High per capita income and increasing healthcare expenditure are among the key factors expected to drive the market.
Furthermore, the adoption of smart devices, coupled with technological advancements such as AI and data analytics, is expected to propel the market. The market is expected to experience the launch of several products in the near future.
For Instance, In February 2018, Novo Nordisk announced the launch of its smart insulin pen, which was expected to be launched in the U.S., depending on FDA approval. In December 2017, Companion Medical launched Inpen, its first smart insulin pen system, in the U.S. It is the only FDA-approved solution that combines an insulin injector pen with an app.
No credit card required*
Publish Date: Jun 11, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Digital Diabetes Management Market
Digital Diabetes Management Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Medtronic PLC | View profile | 95,000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | www.medtronic.com |
| Sanofi SA | View profile | 87,994 | 46, avenue de la Grande Armée, Paris, France, 75017 | www.sanofi.com |
| Insulet Corp | View profile | 3,000 | 100 Nagog Park, Acton, MA, United States, 01720 | www.insulet.com |
| Bayer AG | View profile | 99,723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | www.bayer.com |
| B. Braun Medical | View profile | 10001+ | Bethlehem, Pennsylvania, United States, North America | www.bbraunusa.com |
| PHC Holdings Corp | View profile | 11,897 | 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo, Japan, 105-8433 | www.phchd.com |
| DexCom Inc | View profile | 9,600 | 6340 Sequence Drive, San Diego, CA, United States, 92121 | www.dexcom.com |
| Brigade High Income Founders | View profile | - | - | - |
U.S. digital diabetes management market
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Digital Diabetes Management Market will help companies and investors design strategic landscapes.
Continuous Glucose Monitoring Systems was the largest segment with a revenue share of 43.32% in 2025.
Horizon Databook has segmented the U.S. digital diabetes management market based on smart glucose meters, continuous glucose monitoring systems, smart insulin pens, smart insulin pumps/closed loop systems, apps covering the revenue growth of each sub-segment from 2021 to 2033.
In North America, the U.S. dominated the market owing to a high prevalence of diabetes and the availability of favorable reimbursement policies. High per capita income and increasing healthcare expenditure are among the key factors expected to drive the market.
Furthermore, the adoption of smart devices, coupled with technological advancements such as AI and data analytics, is expected to propel the market. The market is expected to experience the launch of several products in the near future.
For Instance, In February 2018, Novo Nordisk announced the launch of its smart insulin pen, which was expected to be launched in the U.S., depending on FDA approval. In December 2017, Companion Medical launched Inpen, its first smart insulin pen system, in the U.S. It is the only FDA-approved solution that combines an insulin injector pen with an app.
- U.S. Digital Diabetes Management Market Product Outlook (Revenue, USD Million , 2021-2033)
- Smart Glucose Meters
- Continuous Glucose Monitoring Systems
- Smart Insulin Pens
- Smart Insulin Pumps/Closed Loop Systems
- Apps
- U.S. Digital Diabetes Management Market Type Outlook (Revenue, USD Million , 2021-2033)
- Wearable Devices
- Hand Held Devices
Reasons to subscribe to digital diabetes management market databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of digital diabetes management market databook
- Our clientele includes a mix of digital diabetes management market companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. digital diabetes management market, including forecasts for subscribers. This country databook contains high-level insights into U.S. digital diabetes management market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. Digital Diabetes Management Market, 2021-2033 (US$M)
US Product - Digital Diabetes Management Market, 2025 - 2033 (US$M)
